METHODS OF CONJUGATION Russian patent published in 2016 - IPC A61K39/395 A61K31/5365 A61K47/46 

Abstract RU 2595424 C2

FIELD: biotechnology.

SUBSTANCE: present invention relates to biotechnology. Disclosed is a method of preparing a purified conjugate in a solution, involving bringing into contact a maytansinoid molecule containing a thiol group, with a heterobifunctional linker reagent for covalent bonding of linker to maytansinoid molecule, then conjugation of antibody with maytansinoid molecule associated with linkers, by reacting obtained crude mixture with antibody in a solution having pH from approximately 4 to approximately 9, and applying to produced mixture tangential flow filtration, dialysis, gel filtration, adsorption chromatography, selective deposition or combination thereof to produce purified conjugate.

EFFECT: disclosed method requires no purification of intermediate compounds, provides high output of conjugates of high purity and homogeneity without inter-chain crosslinking and inactivated residues of linker and can find further application in production of medicinal preparations based on corresponding conjugates.

9 cl, 25 dwg, 1 tbl, 8 ex

Similar patents RU2595424C2

Title Year Author Number
CONJUGATION METHODS 2010
  • Kellog Brenda A.
  • Singkh Radzhieva
  • Chari Ravi V. Dzh.
RU2765240C2
CD37 BINDING MOLECULES AND IMMUNOCONJUGATES 2011
  • Dekert Dzhutta
  • Park Piter
  • Tavares Deniel
  • Rui Linyun
RU2610662C9
ANTIBODIES TO FOLIC ACID RECEPTOR 1, THEIR IMMUNOCONJUGATES AND APPLICATION 2011
  • Eb Olga
  • Tavares Deniel
  • Rui Linyun
  • Pejn Dzhillian
  • Goldmakher Viktor S.
RU2610663C2
ANTI-CD20 ANTIBODIES AND THEREOF APPLICATION 2011
  • Dekkert Jutta
  • Rui Lintszjun'
  • Park Piter Ju.
RU2573994C2
ANTIBODIES AGAINST FOLIC ACID RECEPTOR 1, THEIR IMMUNOCONJUGATES AND USE 2011
  • Eb Olga
  • Tavares Deniel
  • Rui Linyun
  • Pejn Dzhillian
  • Goldmakher Viktor S.
RU2740479C2
CD37-BINDING MOLECULES AND THEIR IMMUNOCONJUGATES 2011
  • Dekert Dzhutta
  • Park Piter
  • Tavares Deniel
  • Rui Linyun
RU2742743C2
CD138-TARGETED CELL AGENTS AND USING THEM 2008
  • Kraus,Ehl'Mar
  • Brjukher,Kristof
  • Delken,Benzhamin
  • Germer,Mattias
  • Tseng,Shteffen
  • Osterrot,Frank
  • Uehrek,Kristof
  • Ajgner,Zil'Ke
  • Shul'Ts,Gregor
RU2537265C2
METHOD FOR IMPROVING TARGETED ACTION OF CD138 EXPRESSING TUMOUR CELLS AND AGENTS TO THIS EFFECT 2008
  • Delken Benzhamin
  • Uehrek Kristof
  • Anderson Kennet
  • Khidesima Teru
  • Brjukher Kristof
RU2486203C2
MATERIALS AND METHODS ASSOCIATED WITH LINKERS FOR USE IN DRUG AND PROTEIN CONJUGATES 2015
  • Bakster Entoni Devid
  • Bersell Kristofer Majkl
  • Mansell Devid Dzhejms
  • Mizlivi Dzhastina Khelena
  • Terlvej Dzhenni
RU2737553C2
ANTI-CD138 IMMUNOCONJUGATES AND USING THEM 2008
  • Kraus, Ehl'Mar
  • Brjukher, Kristof
  • Delken, Benzhamin
  • Tseng, Shteffen
  • Osterrot, Frank
  • Uehrek, Kristof
  • Ajgner, Zil'Ke
  • Germer, Mattias
RU2547939C2

RU 2 595 424 C2

Authors

Kellog Brenda A.

Singkh Radzhieva

Chari Ravi V. Dzh.

Dates

2016-08-27Published

2010-06-02Filed